|
Parameter
|
Characteristic
|
No. patients (%)
|
AURKA intensity
|
Statistics
|
P value
|
|---|
|
Gender
|
Female
|
26 (40.0)
|
6.19 ± 0.97
|
t = − 1.458
|
0.150
|
|
Male
|
39 (60.0)
|
6.63 ± 1.47
| | |
|
Age
|
< 68
|
31 (47.7)
|
6.28 ± 1.17
|
t = 1.022
|
0.311
|
|
≥ 68
|
34 (52.3)
|
6.62 ± 1.41
| | |
|
Location*
|
Stomach
|
43 (66.2)
|
6.14 ± 1.25
|
F = 4.306
|
0.018
|
|
Non-stomach
|
16 (24.6)
|
6.95 ± 0.99
| | |
|
Metastasis
|
6 (9.2)
|
7.39 ± 1.74
| | |
|
Risk*
|
High
|
17 (26.2)
|
7.54 ± 1.30
|
F = 11.898
|
< 0.001
|
|
Intermediate
|
9 (13.8)
|
5.75 ± 0.54
| | |
|
Low
|
22 (33.8)
|
6.06 ± 0.94
| | |
|
Very low
|
11 (16.9)
|
5.66 ± 0.74
| | |
|
Stage*
|
IV
|
9 (13.8)
|
7.94 ± 1.63
|
F = 10.686
|
< 0.001
|
|
III
|
9 (13.8)
|
6.85 ± 0.89
| | |
|
II
|
8 (12.3)
|
7.13 ± 1.55
| | |
|
I
|
39 (60.0)
|
5.89 ± 0.84
| | |
|
Mutation
|
Sensitive
|
56 (86.2)
|
6.39 ± 1.21
|
F = 2.541
|
0.087
|
|
Resistance
|
7 (10.8)
|
7.33 ± 1.84
| | |
|
N/A
|
2 (3.1)
|
5.29 ± 0.20
| | |
|
Mutation
|
Sensitive
|
56 (88.9)
|
6.39 ± 1.21
|
t = 1.814
|
0.075
|
|
Resistance
|
7 (11.1)
|
7.33 ± 1.84
| | |
- *P < 0.05 was considered statistically significant
